PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

SHE:301230 Revenue

PharmaResources (Shanghai) had revenue of 172.29M CNY in the quarter ending March 31, 2026, with 1.69% growth. This brings the company's revenue in the last twelve months to 691.21M, up 18.52% year-over-year. In the year 2025, PharmaResources (Shanghai) had annual revenue of 688.35M with 26.43% growth.

• Revenue (ttm): 691.21M
• Revenue Growth: +18.52%
• P/S Ratio: 7.00
• Revenue / Employee: 598.45K
• Employees: 1,155
• Market Cap: 4.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	688.35M	143.88M	26.43%
Dec 31, 2024	544.47M	54.75M	11.18%
Dec 31, 2023	489.72M	10.83M	2.26%
Jan 1, 2023	478.88M	30.67M	6.84%
Jan 1, 2022	448.21M	165.22M	58.39%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error